Jump to section
Apollo Neuro's mission is to empower people to take control of their health and well-being, effortlessly.
The last few years has seen huge growth for the wellness industry, with around 10% annual growth. Indeed, the wellness economy is expected to be worth as much as $7 trillion in 2025. A great deal of startups in the space are building mental health platforms, while consumer supplements are also on the rise.
Apollo Neuro is doing things a little differently, with a research-based wearable which uses touch therapy to reduce stress and anxiety, and improve sleep, energy, and focus. The company was spun out of the work of co-founder Dr. David Rabin at the University of Pittsburgh.
Considering that the wearable is patented and is the first of its kind to be backed by scientific research, some big things could be on the horizon. The company has been growing steadily since launching in 2018, quadrupling its headcount along the way. Now with major funding secured, Apollo will be eyeing up a period of accelerated growth.
Kirsty
Company Specialist at Welcome to the Jungle
Sep 2023
$6m
EARLY VC
Mar 2022
$15m
SERIES A
Dr. David Rabin, MD
(Chief Innovation Officer)Neuroscientist and board-certified Psychiatrist. Former Physician & Research Scientist at the University of Pittsburgh Medical Center. Executive Director of the Board of Medicine.
Kathryn Fantauzzi
(CEO)Previously worked on the development and launch of a $20M tech commercialization accelerator through the NY State Energy Research & Development Authority (NYSERDA). Also led Green Jobs Green NY, a nationally-recognized revolving loan fund for investment in sustainability projects and economic development.